The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2
Open accessAbstract
Transcription factor Nrf2 is a major regulator of genes encoding phase 2 detoxifying enzymes and antioxidant stress proteins in response to electrophilic agents and oxidative stress. In the absence of such stimuli, Nrf2 is inactive owing to its cytoplasmic retention by Keap1 and rapid degradation through the proteasome system. We examined the contribution of Keap1 to the rapid turnover of Nrf2 (half-life of less than 20 min) and found that a direct association between Keap1 and Nrf2 is required for Nrf2 degradation. In a series of domain function analyses of Keap1, we found that both the BTB and intervening-region (IVR) domains are crucial for Nrf2 degradation, implying that these two domains act to recruit ubiquitin-proteasome factors. Indeed, Cullin 3 (Cul3), a subunit of the E3 ligase complex, was found to interact specifically with Keap1 in vivo. Keap1 associates with the N-terminal region of Cul3 through the IVR domain and promotes the ubiquitination of Nrf2 in cooperation with the Cul3-Roc1 complex. These results thus provide solid evidence that Keap1 functions as an adaptor of Cul3-based E3 ligase. To our knowledge, Nrf2 and Keap1 are the first reported mammalian substrate and adaptor, respectively, of the Cul3-based E3 ligase system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nrf2 regulates the expression of a multitude of antioxidant and phase II enzyme genes and is negatively regulated by Kelch-like ECH-associated protein (Keap1) [49], a substrate adaptor protein that binds to Nrf2 in the cytosol to facilitate its polyubiquitination by the Cullin 3 (Cul3) E3 ubiquitin ligase for proteasomal degradation [50,51,52].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [51]
In the citing paper
“The actual mechanism by which rapamycin increases Nrf2 levels is not completely elucidated; however, this seems to occur at the level of protein stabilization rather than increasing Nrf2 gene expression because rapamycin did not increase Nrf2 mRNA levels, but decreased Keap1, a protein that triggers Nrf2 degradation (Kobayashi et al., 2004).”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Kobayashi et al., 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,301
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival
Cullinan, S. B., Zhang, D. D., Hannink, M., Arvisais, E. W., Kaufman, R. J., & Diehl, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7198-7209.2003 · Cited by 1,233
Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element
Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140229 · Cited by 1,232
McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141
The structure of the G protein heterotrimer Giα1β1γ2
Wall, M. A., Coleman, D. E., Lee, E. N., Iñiguez-Lluhı́, J. A., Posner, B. A., Gilman, A. G., & Sprang, S. R. (1995) · Cell · doi:10.1016/0092-8674(95)90220-1 · Cited by 1,140
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · cited 5×
“The association between Cul3 and Keap1 Cys point mutants (27) was examined by immunoprecipitation (upper panel) as described above.”
BackgroundMethodInfluential
Cited by
Sorted by citations
Items 401–500 of 1,003
Tao, S., de la Vega, M. R., Chapman, E., Ooi, A., & Zhang, D. D. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22745 · Cited by 136
A Protective Role of the NRF2-Keap1 Pathway in Maintaining Intestinal Barrier Function
Wen, Z., Liu, W., Li, X., Chen, W., Liu, Z., Wen, J., & Liu, Z. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1759149 · Cited by 142
Subcellular localization and cytoplasmic complex status of endogenous Keap1
Watai, Y., Kobayashi, A., Nagase, H., Mizukami, M., McEvoy, J. D., Singer, J. D., Itoh, K., & Yamamoto, M. P. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01118.x · Cited by 141
Wang, X.-J., Sun, Z., Chen, W., Li, Y., Villeneuve, N. F., & Zhang, D. D. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.003 · Cited by 135
The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
Cuadrado, A., Moreno-Murciano, P., & Pedraza‐Chaverrí, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/13543780802716501 · Cited by 135
Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
Muscarella, L. A., Parrella, P., D’Alessandro, V., la Torre, A., Barbano, R., Fontana, A., Tancredi, A., Guarnieri, V., Balsamo, T., Coco, M., et al. (2011) · Epigenetics · doi:10.4161/epi.6.6.15773 · Cited by 134
Alves-Lopes, R., Neves, K. B., Tostes, R. C., Montezano, A. C. I., & Touyz, R. M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06163 · Cited by 133
Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 143
The hepatotoxic metabolite of acetaminophen directly activates the Keap1‐Nrf2 cell defense system†
Copple, I. M., Goldring, C. E., Jenkins, R. E., Chia, A. J. L., Randle, L. E., Hayes, J. D., Kitteringham, N. R., & Park, B. K. (2008) · Hepatology · doi:10.1002/hep.22472 · Cited by 133
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
Kang, Y. P., Torrente, L., Falzone, A., Elkins, C. M., Liu, M., Asara, J. M., Dibble, C. C., & DeNicola, G. M. (2019) · eLife · doi:10.7554/elife.45572 · Cited by 129
Zhang, Y., & Xiang, Y. (2016) · Biochemical Journal · doi:10.1042/bj20151182 · Cited by 125
Adelusi, T. I., Du, L., Meng, H., Zhou, X., Qian, X., Chowdhury, A., Sun, Y., Lü, Q., & Yin, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109732 · Cited by 133
Silwal, P., Kim, J. K., Kim, Y. J., & Jo, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01649 · Cited by 129
RLE-1, an E3 Ubiquitin Ligase, Regulates C. elegans Aging by Catalyzing DAF-16 Polyubiquitination
Li, W., Gao, B., Lee, S., Bennett, K. L., & Fang, D. (2007) · Developmental Cell · doi:10.1016/j.devcel.2006.12.002 · Cited by 133
Camp, N. D., James, R. G., Dawson, D. W., Yan, F., Davison, J. M., Houck, S. A., Tang, X., Zheng, N., Major, M. B., & Moon, R. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316471 · Cited by 128
Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells
Iso, T., Suzuki, T., Baird, L., & Yamamoto, M. P. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00389-16 · Cited by 130
Nestin regulates cellular redox homeostasis in lung cancer through the Keap1–Nrf2 feedback loop
Wang, J., Lu, Q., Cai, J., Wang, Y., Lai, X., Qiu, Y., Huang, Y., Ke, Q., Zhang, Y., Guan, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12925-9 · Cited by 130
Li, N., & Nel, A. E. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.88 · Cited by 130
Higgins, L. G., Cavin, C., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.09.018 · Cited by 129
NRF2, cancer and calorie restriction
Martín‐Montalvo, A., Villalba, J. M., Navas, P., & de Cabo, R. (2010) · Oncogene · doi:10.1038/onc.2010.492 · Cited by 129
Nrf2 Improves Leptin and Insulin Resistance Provoked by Hypothalamic Oxidative Stress
Yagishita, Y., Uruno, A., Fukutomi, T., Saito, R., Saigusa, D., Pi, J., Fukamizu, A., Sugiyama, F., Takahashi, S., & Yamamoto, M. P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.064 · Cited by 129
KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease
Naidu, S. D., & Dinkova‐Kostova, A. T. (2020) · Open Biology · doi:10.1098/rsob.200105 · Cited by 135
Liu, J., Hu, Y., Feng, Y., Jiang, Y., Guo, Y., Liu, Y., Chen, X., Yang, J., Chen, Y., Mao, Q.-S., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01620-z · Cited by 130
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
von Otter, M., Landgren, S., Nilsson, S., Celojevic, D., Bergström, P., Håkansson, A. S., Nissbrandt, H., Droździk, M., Białecka, M. A., Kurzawski, M., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-36 · Cited by 128
Denis, M.-C., Desjardins, Y., Fürtös, A., Marcil, V., Dudonné, S., Montoudis, A., Garofalo, C., DELVIN, E. E., Marette, A., & Levy, E. H. (2014) · Clinical Science · doi:10.1042/cs20140210 · Cited by 126
Zhang, Y. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr255 · Cited by 129
Kahroba, H., Ramezani, B., Maadi, H., Sadeghi, M. R., Jaberie, H., & Ramezani, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101211 · Cited by 130
The Nrf2 Pathway in Ischemic Stroke: A Review
Farina, M., Vieira, L. E., Buttari, B., Profumo, E., & Saso, L. (2021) · Molecules · doi:10.3390/molecules26165001 · Cited by 129
Lee, J., & Hyun, D. (2023) · Antioxidants · doi:10.3390/antiox12040918 · Cited by 142
Kovac, S., Dinkova‐Kostova, A. T., Herrmann, A. M., Melzer, N., Meuth, S. G., & Gorji, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091935 · Cited by 129
Nrf2-Mediated Regulation of Skeletal Muscle Glycogen Metabolism
Uruno, A., Yagishita, Y., Katsuoka, F., Kitajima, Y., Nunomiya, A., Nagatomi, R., Pi, J., Biswal, S. S., & Yamamoto, M. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.01095-15 · Cited by 126
Lee, S., Lim, M., Kim, M., Yu, C., Yun, Y., Ahn, J., & Song, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.038 · Cited by 127
Zhang, L., Du, L., Shen, C., Yang, Y., & Poovaiah, B. W. (2014) · The Plant Journal · doi:10.1111/tpj.12473 · Cited by 124
Bertrand, H. C., Schaap, M., Baird, L., Georgakopoulos, N., Fowkes, A., Thiollier, C., Kaatchi, H., Dinkova‐Kostova, A. T., & Wells, G. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00602 · Cited by 123
Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00065-13 · Cited by 123
LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases
Abe, T., Umeki, I., Kanno, S., Inoue, S., Niihori, T., & Aoki, Y. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0395-5 · Cited by 120
Sánchez-Ortega, M., Carrera, A. C., & Garrido, A. (2021) · Cells · doi:10.3390/cells10081879 · Cited by 130
Silva, M. M., Rocha, C. R. R., Kinker, G. S., Pelegrini, A. L., & Menck, C. F. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-54065-6 · Cited by 128
Mendonca, P., & Soliman, K. F. A. (2020) · Antioxidants · doi:10.3390/antiox9080659 · Cited by 126
Liu, Z., Nan, P., Gong, Y., Tian, L., Yin, Z., & Wu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114897 · Cited by 125
Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype
Devling, T. W. P., LINDSAY, C. D., McLellan, L. I., McMahon, M. J., & Hayes, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501475102 · Cited by 122
Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans
Knatko, E. V., Ibbotson, S. H., Zhang, Y., Higgins, M., Fahey, J. W., Talalay, P., Dawe, R. S., Ferguson, J., Huang, J. T.-J., Clarke, R. G., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0362 · Cited by 124
Keller, U. A. D., Huber, M., Beyer, T. A., Kümin, A., Siemes, C., Braun, S., Bugnon, P., Mitropoulos, V., Johnson, D. A., Johnson, J. A., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3773-3784.2006 · Cited by 122
Hyperoxia sensing: From molecular mechanisms to significance in disease
Gore, A., Muralidhar, M., Espey, M. G., Degenhardt, K., & Mantell, L. L. (2010) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.492254 · Cited by 123
Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
Reductive Stress Linked to Small HSPs, G6PD, and Nrf2 Pathways in Heart Disease
Brewer, A. C., Mustafi, S. B., Murray, T. V., Rajasekaran, N. S., & Benjamin, I. J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4914 · Cited by 121
Petrelli, A., Perra, A., Corà, D., Sulas, P., Menegon, S., Manca, C., Migliore, C., Kowalik, M. A., Ledda‐Columbano, G. M., Giordano, S., et al. (2013) · Hepatology · doi:10.1002/hep.26616 · Cited by 119
The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses
Lee, Y.-R., Yuan, W.-C., Ho, H.-C., Chen, C.-H., Shih, H., & Chen, R. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.62 · Cited by 121
The role of COX-2 and Nrf2/ARE in anti-inflammation and antioxidative stress: Aging and anti-aging
Luo, C., Urgard, E., Vooder, T., & Metspalu, A. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.04.002 · Cited by 121
Protective Effect of Carnosine During Nitrosative Stress in Astroglial Cell Cultures
Calabrese, V., Colombrita, C., Guagliano, E., Sapienza, M. A., Ravagna, A., Cardile, V., Scapagnini, G., Santoro, A. M., Mangiameli, A., Butterfield, D. A., et al. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6874-8 · Cited by 119
Sabouny, R., Fraunberger, E. A., Geoffrion, M., Ng, A. C., Baird, S. D., Screaton, R. A., Milne, R. W., McBride, H. M., & Shutt, T. E. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6855 · Cited by 119
Resveratrol ameliorates rheumatoid arthritis via activation of SIRT1‐Nrf2 signaling pathway
Wang, G., Xie, X., Yuan, L., Qiu, J., Duan, W., Xu, B., & Chen, X. (2019) · BioFactors · doi:10.1002/biof.1599 · Cited by 118
The role of natural products in revealing NRF2 function
Zhang, D. D., & Chapman, E. (2020) · Natural Product Reports · doi:10.1039/c9np00061e · Cited by 123
Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Azami, N., Hamzehlou, S., Farahani, M. V., Hushmandi, K., Ashrafizadeh, M., et al. (2021) · Antioxidants · doi:10.3390/antiox10030349 · Cited by 123
Zhang, X.-W., Feng, N., Liu, Y.-C., Guo, Q., Wang, J., Bai, Y.-Z., Ye, X., Yang, Z., Yang, H., Liu, Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0789 · Cited by 122
Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy?
Wu, T., Harder, B. G., Wong, P. K., Lang, J. E., & Zhang, D. D. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22202 · Cited by 119
Williamson, T. P., Johnson, D. A., & Johnson, J. A. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.015 · Cited by 121
Keap1 as the redox sensor of the antioxidant response
Sihvola, V., & Levonen, A. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.10.010 · Cited by 120
Ferroptosis: An emerging therapeutic opportunity for cancer
Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 120
Circadian Control of Mitochondria in Reactive Oxygen Species Homeostasis
Mezhnina, V., Ebeigbe, O. P., Poe, A., & Kondratov, R. V. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0274 · Cited by 123
Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease
Ghosh, N., Ghosh, R. B., & Mandal, S. C. (2011) · Free Radical Research · doi:10.3109/10715762.2011.574290 · Cited by 118
Therapeutic Approaches to Alzheimer’s Disease Through Modulation of NRF2
Bahn, G., & Jo, D. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-08523-5 · Cited by 118
An internal ribosomal entry site mediates redox-sensitive translation of Nrf2
Li, W., Thakor, N., Xu, E. Y., Huang, Y. S., Chen, C., Yu, R., Holčı́k, M., & Kong, A. T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1048 · Cited by 116
Nrf2 is a potential therapeutic target in radioresistance in human cancer
Zhou, S., Ye, W., Shao, Q., Zhang, M., & Liang, J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.09.001 · Cited by 115
DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer
Zhang, Q., Zhang, Z.-Y., Du, H., Li, S., Tu, R., Jia, Y., Zheng, Z., Song, X., Du, R., & Zhang, X. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0303-z · Cited by 117
Mechanisms for Countering Oxidative Stress and Damage in Retinal Pigment Epithelium
Plafker, S. M., O'Mealey, G. B., & Szweda, L. I. (2012) · International review of cytology · doi:10.1016/b978-0-12-394309-5.00004-3 · Cited by 121
Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration.
Handa, J. T., Cano, M., Wang, L., Datta, S., & Liu, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.013 · Cited by 112
Nrf2–ARE signaling pathway and natural products for cancer chemoprevention
Zhao, C. R., Gao, Z. H., & Qu, X. J. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.06.012 · Cited by 114
Ni, H., Peng, L., Gao, X., Ji, H., Ma, J.-X., Li, Y., & Jiang, S. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.10.040 · Cited by 114
Protective Functions of Heme Oxygenase-1 and Carbon Monoxide in the Respiratory System
Ryter, S. W., Kim, H. P., Nakahira, K., Zuckerbraun, B. S., Morse, D., & Choi, A. M. K. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1811 · Cited by 114
Keap1‐Nrf2 activation in the presence and absence of DJ‐1
Gan, L., Johnson, D. A., & Johnson, J. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07138.x · Cited by 113
He, X., Lin, G. X., Chen, M. G., Zhang, J. X., & Ma, Q. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm081 · Cited by 113
Lee, D.-Y., Song, M.-Y., & Kim, E. (2021) · Antioxidants · doi:10.3390/antiox10050743 · Cited by 112
Ogborne, R. M., Rushworth, S. A., & O'Connell, M. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183745.37161.6e · Cited by 113
WDR23 regulates NRF2 independently of KEAP1
Lo, J. Y., Spatola, B. N., & Curran, S. P. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006762 · Cited by 116
Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway
Frandsen, J. R., & Narayanasamy, P. (2017) · Redox Biology · doi:10.1016/j.redox.2017.10.015 · Cited by 118
Li, L., Kobayashi, M., Kaneko, H., Nakajima‐Takagi, Y., Nakayama, Y., & Yamamoto, M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708702200 · Cited by 111
New Directions in Toxicity Testing
Krewski, D. R., Westphal, M., Al‐Zoughool, M., Croteau, M. C., & Andersen, M. E. (2011) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031210-101153 · Cited by 113
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2
Beury, D. W., Carter, K. A., Nelson, C. E., Sinha, P., Hanson, E. M., Nyandjo, M., Fitzgerald, P., Majeed, A., Wali, N., & Ostrand‐Rosenberg, S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501785 · Cited by 115
p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex
Tao, S., Liu, P., Luo, G., de la Vega, M. R., Chen, R., Wu, T., Tillotson, J., Chapman, E., & Zhang, D. D. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00660-16 · Cited by 116
Sitthideatphaiboon, P., Galán‐Cobo, A., Negrao, M. V., Qu, X. H., Poteete, A., Zhang, F., Liu, D. D., Lewis, W. E., Kemp, H. N., Lewis, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2859 · Cited by 115
Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes
Zhang, J., Hosoya, T., Maruyama, A., Nishikawa, K., Maher, J. M., Ohta, T., Motohashi, H., Fukamizu, A., Shibahara, S., Itoh, K., et al. (2007) · Biochemical Journal · doi:10.1042/bj20061611 · Cited by 111
Na, H., & Surh, Y. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20225 · Cited by 111
Yoon, D. S., Choi, Y., & Lee, J. W. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.3 · Cited by 105
Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells
Li, C.-Q., Kim, M. Y., Godoy, L. C., Thiantanawat, A., Trudel, L. J., & Wogan, G. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907539106 · Cited by 108
Liao, D., Lv, C., Cao, L., Yao, D., Wu, Y. P., Long, M., Liu, N., & Jiang, P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9268083 · Cited by 112
Crosstalk between Nrf2 and Notch signaling
Wakabayashi, N., Chartoumpekis, D. V., & Kensler, T. W. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.017 · Cited by 109
NRF2 and p53: Januses in cancer?
Rotblat, B., Melino, G., & Knight, R. A. (2012) · Oncotarget · doi:10.18632/oncotarget.754 · Cited by 114
Boddupalli, S. S., Mein, J. R., Lakkanna, S., & James, D. R. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00007 · Cited by 112
Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation
Keleku-Lukwete, N., Suzuki, M., Otsuki, A., Tsuchida, K., Katayama, S., Hayashi, M., Naganuma, E., Moriguchi, T., Tanabe, O., Engel, J. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509158112 · Cited by 108
Michalska, P., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080740 · Cited by 119
Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress
Alonso-Piñero, J. A., González-Rovira, A., Sánchez-Gomar, I., Moreno, J. A., & Durán-Ruiz, M. C. (2021) · Antioxidants · doi:10.3390/antiox10091463 · Cited by 120
The KEAP1-NRF2 System and Neurodegenerative Diseases
Uruno, A., & Yamamoto, M. P. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0234 · Cited by 113
Keap1: One stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL
Tian, H., Zhang, B., Di, J., Jiang, G., Chen, F., Li, H., Li, L., Pei, D., & Zheng, J. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.007 · Cited by 110
Chemistry of the Cysteine Sensors in Kelch-Like ECH-Associated Protein 1
Holland, R., & Fishbein, J. C. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3273 · Cited by 109
Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
Campbell, M. R., Karaca, M., Adamski, K. N., Chorley, B. N., Wang, X., & Bell, D. A. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/120305 · Cited by 112
Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease
Davies, D. A., Adlimoghaddam, A., & Albensi, B. C. (2021) · Cells · doi:10.3390/cells10081884 · Cited by 112
Chang, K. S., Chen, Y., Zhang, X., Zhang, W., Xu, N., Zeng, B., Wang, Y., Feng, T., Dai, B., Xu, F., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-4001 · Cited by 111
Regulation of Proteasome Activity by (Post-)transcriptional Mechanisms
Kors, S., Geijtenbeek, K. W., Reits, E. A., & Schipper-Krom, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00048 · Cited by 111
Hahn, M. E., Timme‐Laragy, A. R., Karchner, S. I., & Stegeman, J. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.022 · Cited by 106
Metadata
- Authors
- Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M.
- Affiliations
- University of Tsukuba (JP)
- Hiroshima University (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yamamoto, Masayuki
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2004-08-01
- Volume
- 24
- Issue
- 16
- Pages
- 7130-7139
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC479737
- OpenAlex
- W2155324869
- Cited by
- 2,224
- References
- 33
- Citations by year
- 2026: 100 · 2025: 102 · 2024: 116 · 2023: 137 · 2022: 154 · 2021: 123 · 2020: 182 · 2019: 121 · 2018: 122 · 2017: 122 · 2016: 140 · 2015: 132 · 2014: 95 · 2013: 100 · 2012: 84
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Keap1, Nrf2, CUL3, E3 ubiquitin ligase, adaptor proteins, proteasomal degradation, ubiquitination, BTB domain, ROC1, oxidative stress, antioxidant response
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Cell Line, Cysteine Endopeptidases, DNA-Binding Proteins, Humans, Multienzyme Complexes, Proteins, Recombinant Fusion Proteins, Transcription Factors, Trans-Activators, Protein Structure, Tertiary, Oxidative Stress, Cell Cycle Proteins, Ubiquitin, Ubiquitin-Protein Ligases, Cullin Proteins, Macromolecular Substances, Proteasome Endopeptidase Complex, Intracellular Signaling Peptides and Proteins, Basic-Leucine Zipper Transcription Factors, NF-E2-Related Factor 2, Mice, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review